JP2023524445A5 - - Google Patents

Info

Publication number
JP2023524445A5
JP2023524445A5 JP2022565804A JP2022565804A JP2023524445A5 JP 2023524445 A5 JP2023524445 A5 JP 2023524445A5 JP 2022565804 A JP2022565804 A JP 2022565804A JP 2022565804 A JP2022565804 A JP 2022565804A JP 2023524445 A5 JP2023524445 A5 JP 2023524445A5
Authority
JP
Japan
Application number
JP2022565804A
Other languages
Japanese (ja)
Other versions
JP2023524445A (ja
JPWO2021222347A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/029545 external-priority patent/WO2021222347A1/en
Publication of JP2023524445A publication Critical patent/JP2023524445A/ja
Publication of JPWO2021222347A5 publication Critical patent/JPWO2021222347A5/ja
Publication of JP2023524445A5 publication Critical patent/JP2023524445A5/ja
Pending legal-status Critical Current

Links

JP2022565804A 2020-04-29 2021-04-28 医薬製剤 Pending JP2023524445A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063017061P 2020-04-29 2020-04-29
US63/017,061 2020-04-29
PCT/US2021/029545 WO2021222347A1 (en) 2020-04-29 2021-04-28 Pharmaceutical formulation

Publications (3)

Publication Number Publication Date
JP2023524445A JP2023524445A (ja) 2023-06-12
JPWO2021222347A5 JPWO2021222347A5 (https=) 2024-03-28
JP2023524445A5 true JP2023524445A5 (https=) 2024-03-28

Family

ID=76099008

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022565804A Pending JP2023524445A (ja) 2020-04-29 2021-04-28 医薬製剤

Country Status (9)

Country Link
US (1) US20230167176A1 (https=)
EP (1) EP4142789A1 (https=)
JP (1) JP2023524445A (https=)
KR (1) KR20230004798A (https=)
CN (1) CN115461080A (https=)
AU (1) AU2021265108A1 (https=)
CA (1) CA3173934A1 (https=)
IL (1) IL297081A (https=)
WO (1) WO2021222347A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202415407A (zh) * 2022-06-30 2024-04-16 中國大陸商蘇州創勝醫藥集團有限公司 穩定之包含抗cldn18.2抗體的藥物製劑

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4475196A (en) 1981-03-06 1984-10-02 Zor Clair G Instrument for locating faults in aircraft passenger reading light and attendant call control system
US4447233A (en) 1981-04-10 1984-05-08 Parker-Hannifin Corporation Medication infusion pump
US4439196A (en) 1982-03-18 1984-03-27 Merck & Co., Inc. Osmotic drug delivery system
US4447224A (en) 1982-09-20 1984-05-08 Infusaid Corporation Variable flow implantable infusion apparatus
US4487603A (en) 1982-11-26 1984-12-11 Cordis Corporation Implantable microinfusion pump system
US4486194A (en) 1983-06-08 1984-12-04 James Ferrara Therapeutic device for administering medicaments through the skin
US4596556A (en) 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
US4751180A (en) 1985-03-28 1988-06-14 Chiron Corporation Expression using fused genes providing for protein product
US4935233A (en) 1985-12-02 1990-06-19 G. D. Searle And Company Covalently linked polypeptide cell modulators
ATE243754T1 (de) 1987-05-21 2003-07-15 Micromet Ag Multifunktionelle proteine mit vorbestimmter zielsetzung
US4790824A (en) 1987-06-19 1988-12-13 Bioject, Inc. Non-invasive hypodermic injection device
US4941880A (en) 1987-06-19 1990-07-17 Bioject, Inc. Pre-filled ampule and non-invasive hypodermic injection device assembly
US5312335A (en) 1989-11-09 1994-05-17 Bioject Inc. Needleless hypodermic injection device
US5064413A (en) 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
US5383851A (en) 1992-07-24 1995-01-24 Bioject Inc. Needleless hypodermic injection device
EP1299419A2 (en) 2000-05-24 2003-04-09 Imclone Systems, Inc. Bispecific immunoglobulin-like antigen binding proteins and method of production
JP2008512352A (ja) 2004-07-17 2008-04-24 イムクローン システムズ インコーポレイティド 新規な四価の二重特異性抗体
CA2697922A1 (en) 2007-08-28 2009-03-12 Biogen Idec Ma Inc. Compositions that bind multiple epitopes of igf-1r
KR20180008921A (ko) * 2012-11-01 2018-01-24 애브비 인코포레이티드 항-vegf/dll4 이원 가변 도메인 면역글로불린 및 이의 용도
EP3498263B1 (en) * 2016-08-10 2023-11-29 Celltrion Inc. Stable liquid pharmaceutical preparation for anti-influenza virus antibody
TN2019000225A1 (en) 2017-02-02 2021-01-07 Amgen Res Munich Gmbh Low ph pharmaceutical composition comprising t cell engaging antibody constructs
MX2019013142A (es) * 2017-05-05 2019-12-16 Amgen Inc Composicion farmaceutica que comprende construcciones de anticuerpos biespecificas para mejorar el almacenamiento y la administracion.
CN110869050B (zh) * 2017-07-28 2024-07-02 豪夫迈·罗氏有限公司 双特异性抗体配制剂

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
JP2023524445A5 (https=)
JP2023524444A5 (https=)
BR112023016292A2 (https=)
BR112023011610A2 (https=)
BR112023011539A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)